BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1302 related articles for article (PubMed ID: 27892767)

  • 21. Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.
    Wong KY; Li Z; Zhang X; Leung GK; Chan GC; Chim CS
    Mol Cancer; 2015 Sep; 14():175. PubMed ID: 26410378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of exercise on epigenetic modifications: focus on DNA methylation, histone modifications and non-coding RNAs.
    Zhang J; Tian Z; Qin C; Momeni MR
    Hum Cell; 2024 Jul; 37(4):887-903. PubMed ID: 38587596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation of microRNA genes in multiple myeloma.
    Wong KY; Huang X; Chim CS
    Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics in lung cancer diagnosis and therapy.
    Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
    Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compendium of aberrant DNA methylation and histone modifications in cancer.
    Hattori N; Ushijima T
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple levels of epigenetic control for bone biology and pathology.
    Montecino M; Stein G; Stein J; Zaidi K; Aguilar R
    Bone; 2015 Dec; 81():733-738. PubMed ID: 25865577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation technologies and data analytical approaches for epigenomics.
    Mensaert K; Denil S; Trooskens G; Van Criekinge W; Thas O; De Meyer T
    Environ Mol Mutagen; 2014 Apr; 55(3):155-70. PubMed ID: 24327356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.
    Dupéré-Richer D; Licht JD
    Curr Opin Hematol; 2017 Jul; 24(4):336-344. PubMed ID: 28441149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.
    Rastgoo N; Abdi J; Hou J; Chang H
    J Hematol Oncol; 2017 Jun; 10(1):121. PubMed ID: 28623912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.
    Cazaly E; Charlesworth J; Dickinson JL; Holloway AF
    Mol Med; 2015 Mar; 21(1):400-9. PubMed ID: 25822796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
    Akram F; Tanveer R; Andleeb S; Shah FI; Ahmad T; Shehzadi S; Akhtar AM; Syed G
    Technol Cancer Res Treat; 2024; 23():15330338241250317. PubMed ID: 38780251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetics of Skeletal Diseases.
    Del Real A; Riancho-Zarrabeitia L; López-Delgado L; Riancho JA
    Curr Osteoporos Rep; 2018 Jun; 16(3):246-255. PubMed ID: 29574535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current and potential epigenetic targets in multiple myeloma.
    Pawlyn C; Kaiser MF; Davies FE; Morgan GJ
    Epigenomics; 2014 Apr; 6(2):215-28. PubMed ID: 24811790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics, disease, and therapeutic interventions.
    Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC
    Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-specific histone signature and DNA methylation in multiple myeloma and leukemia cells.
    Foltankova V; Legartova S; Kozubek S; Bartova E
    Neoplasma; 2012; 59(4):450-62. PubMed ID: 22489701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.